🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/05/2015 26,56 27,00 25,76 26,14 -2,13% 4,67% 1.474.200
26/05/2015 26,13 27,02 25,41 26,71 +1,87% 6,16% 2.396.200
22/05/2015 25,03 26,98 25,00 26,22 +8,08% 7,91% 3.891.600
21/05/2015 24,85 25,34 23,38 24,26 -7,55% 7,89% 6.859.800
20/05/2015 23,28 27,49 21,81 26,24 +60,20% 24,40% 20.089.000
19/05/2015 16,18 16,49 15,88 16,38 +2,82% 3,77% 2.643.800
18/05/2015 15,27 15,94 15,12 15,93 +4,73% 5,37% 1.326.700
15/05/2015 15,24 15,45 14,96 15,21 -0,72% 3,22% 831.800
14/05/2015 15,03 15,37 14,45 15,32 +3,03% 6,12% 923.600
13/05/2015 15,28 15,62 14,75 14,87 -2,24% 5,69% 887.700
12/05/2015 15,00 15,45 14,96 15,21 +1,13% 3,27% 1.057.000
11/05/2015 14,70 15,35 14,57 15,04 +2,24% 5,31% 998.800
08/05/2015 15,28 15,35 14,60 14,71 -2,19% 4,91% 1.063.300
07/05/2015 14,59 15,38 13,61 15,04 +1,90% 12,13% 2.160.300
06/05/2015 13,97 14,85 13,52 14,76 +11,40% 9,52% 3.100.700
05/05/2015 13,25 13,79 12,83 13,25 -0,15% 7,25% 1.629.400
04/05/2015 12,80 13,39 12,69 13,27 +4,24% 5,47% 920.400
01/05/2015 12,27 12,75 12,12 12,73 +4,34% 5,13% 692.300
30/04/2015 12,88 13,03 12,01 12,20 -6,08% 7,92% 1.344.700
29/04/2015 12,95 13,23 12,73 12,99 -0,54% 3,86% 644.700
28/04/2015 13,22 13,49 12,61 13,06 -1,14% 6,66% 1.020.700
27/04/2015 13,48 13,94 12,93 13,21 -1,56% 7,49% 841.000
24/04/2015 13,66 13,78 13,37 13,42 -1,76% 3,00% 273.300
23/04/2015 13,53 13,78 13,27 13,66 +1,04% 3,77% 541.500
22/04/2015 13,43 13,72 13,24 13,52 +0,30% 3,57% 470.200
21/04/2015 13,56 13,70 13,30 13,48 -0,44% 2,95% 538.200
20/04/2015 13,30 13,68 12,90 13,54 +2,27% 5,86% 627.600
17/04/2015 13,35 13,56 13,09 13,24 -1,71% 3,52% 676.800
16/04/2015 13,76 13,92 13,43 13,47 -2,46% 3,56% 641.000
15/04/2015 13,61 13,98 13,35 13,81 +1,84% 4,63% 657.300